Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Denali Therapeutics (DNLI) Change in Acquisitions & Divestments (2017 - 2026)

Denali Therapeutics has reported Change in Acquisitions & Divestments over the past 9 years, most recently at $275.0 million for Q4 2025.

  • Quarterly Change in Acquisitions & Divestments fell 21.65% to $275.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $706.0 million through Dec 2025, down 38.98% year-over-year, with the annual reading at $706.0 million for FY2025, 38.98% down from the prior year.
  • Change in Acquisitions & Divestments was $275.0 million for Q4 2025 at Denali Therapeutics, up from $107.1 million in the prior quarter.
  • Over five years, Change in Acquisitions & Divestments peaked at $601.1 million in Q3 2023 and troughed at $107.1 million in Q3 2025.
  • The 5-year median for Change in Acquisitions & Divestments is $284.0 million (2021), against an average of $317.0 million.
  • Year-over-year, Change in Acquisitions & Divestments skyrocketed 316.46% in 2023 and then plummeted 67.06% in 2024.
  • A 5-year view of Change in Acquisitions & Divestments shows it stood at $193.8 million in 2021, then skyrocketed by 87.87% to $364.0 million in 2022, then surged by 34.34% to $489.0 million in 2023, then decreased by 28.22% to $351.0 million in 2024, then decreased by 21.65% to $275.0 million in 2025.
  • Per Business Quant, the three most recent readings for DNLI's Change in Acquisitions & Divestments are $275.0 million (Q4 2025), $107.1 million (Q3 2025), and $162.2 million (Q2 2025).